Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

PCRX holding history

Pacira BioSciences, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PCRX overviewAll 13F holders of PCRXFull Q2 2026 holdings

Shares (Q2 2026)
892
Value
$22.6K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of PCRX by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026892$22.6K<0.1%+33+3.8%AddedHolders
Q1 2026859$19.4K<0.1%−217−20.2%ReducedHolders
Q4 20251,076$27.8K<0.1%−67−5.9%ReducedHolders
Q3 20251,143$29.5K<0.1%−944−45.2%ReducedHolders
Q2 20252,087$49.9K<0.1%−183−8.1%ReducedHolders
Q1 20252,270$56.4K<0.1%+537+31.0%AddedHolders
Q4 20241,733$32.6K<0.1%−234−11.9%ReducedHolders
Q3 20241,967$29.6K<0.1%−8,442−81.1%ReducedHolders
Q2 202410,409$297.8K<0.1%−1,333−11.4%ReducedHolders
Q1 202411,742$343.1K<0.1%−916−7.2%ReducedHolders
Q4 202312,658$427.1K<0.1%+1,605+14.5%AddedHolders
Q3 202311,053$339.1K<0.1%+664+6.4%AddedHolders
Q2 202310,389$416.3K<0.1%−933−8.2%ReducedHolders
Q1 202311,322$462.1K<0.1%−658−5.5%ReducedHolders
Q4 202211,980$462.5K<0.1%−1,015−7.8%ReducedHolders
Q3 202212,995$692.0K<0.1%−1,244−8.7%ReducedHolders
Q2 202214,239$830.0K<0.1%−2,608−15.5%ReducedHolders
Q1 202216,847$1.29M<0.1%+614+3.8%AddedHolders
Q4 202116,233$977.0K<0.1%+720+4.6%AddedHolders
Q3 202115,513$869.0K<0.1%+1,754+12.7%AddedHolders
Q2 202113,759$834.0K<0.1%+549+4.2%AddedHolders
Q1 202113,210$926.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.